ARTICLE | Clinical News
Xience Prime regulatory update
November 9, 2009 8:00 AM UTC
Abbott received European approval for expanded CE Marking for use of its Xience V and Xience Prime everolimus-eluting coronary stent systems to treat coronary artery disease in patients with diabetes ...